Project BioShield: what it is, why it is needed, and its accomplishments so far
about
RaxibacumabA systematic review and critical assessment of incentive strategies for discovery and development of novel antibioticsEfficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthraxAgents of Bioterrorism: Curriculum and Pedagogy in an Online Masters CourseBioterrorism: Law Enforcement, Public Health & Role of Oral and Maxillofacial Surgeon in Emergency Preparedness.Biodefense countermeasures: the impact of Title IV of the US Pandemic and All-Hazards Preparedness ActMedical countermeasures for unwanted CBRN exposures: Part I chemical and biological threats with review of recent countermeasure patents.Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entitiesTargeting virulence not viability in the search for future antibacterials.Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen.The biology and future prospects of antivirulence therapies.A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facilityThe secondary cell wall polysaccharide of Bacillus anthracis provides the specific binding ligand for the C-terminal cell wall-binding domain of two phage endolysins, PlyL and PlyG.Progress in the discovery of compounds inhibiting orthopoxviruses in animal models.Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012.Raxibacumab: potential role in the treatment of inhalational anthraxIs 60 days of ciprofloxacin administration necessary for postexposure prophylaxis for Bacillus anthracis?Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health EmergenciesPublic Health Preparedness Funding: Key Programs and Trends From 2001 to 2017FERAL BIOPOLITICSPerspective on Improving Environmental Monitoring of Biothreats
P2860
Q24644111-522410FD-D7FC-4872-901B-A04B711A0DDBQ26783545-599621B7-6557-4264-821A-F1D2158C0FCAQ28389738-21BC2607-6F9B-48E0-AE97-67BC9FCF1B3BQ28655061-E9F9F1F9-DD8E-4DF0-9BD3-B40330D21C3BQ30151977-BF0EC4F0-6C09-4081-9EBA-47E0CD650203Q30229195-538CF59A-D461-47CD-831B-91A42C1867DDQ30245600-F747298D-6134-4F30-949B-D5E5A70684E8Q34241550-49E4E667-04E0-4850-B8CC-0BD4B5DE6AA1Q35023691-090E9DE4-54D0-43F4-B138-443A7B2DA24FQ35900460-8086F49B-3A86-44F7-A5F9-279AF83B91C1Q36397902-40AD6946-CDE3-465B-8B82-935D95EA5E9EQ36715154-2751E92D-1754-48CF-B2EC-5757E16B8405Q36900448-79A6B404-D207-4691-965D-8C6280C0BA9BQ37331541-C50C9786-5E87-41D8-98AA-93930898D58FQ37593480-6B459C7C-4A19-46D1-AA58-E3ADF6DD29BFQ38210540-6523FB06-B5A9-4D97-B24D-BBD48DE2BBB7Q43251072-CADD4D4F-A110-47DB-8528-E25EBB545A5AQ56481192-0B62A0D8-599E-42AD-8592-AE0299177D8CQ56501861-8D482AF0-1DE9-4551-BBA4-67663BC69B92Q58250022-0F5AA6D3-EC62-468F-AF8A-16995B98FA53Q58571866-1B322B30-9615-46A3-AA60-83C7B46585C1
P2860
Project BioShield: what it is, why it is needed, and its accomplishments so far
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Project BioShield: what it is, why it is needed, and its accomplishments so far
@ast
Project BioShield: what it is, why it is needed, and its accomplishments so far
@en
Project BioShield: what it is, why it is needed, and its accomplishments so far
@nl
type
label
Project BioShield: what it is, why it is needed, and its accomplishments so far
@ast
Project BioShield: what it is, why it is needed, and its accomplishments so far
@en
Project BioShield: what it is, why it is needed, and its accomplishments so far
@nl
prefLabel
Project BioShield: what it is, why it is needed, and its accomplishments so far
@ast
Project BioShield: what it is, why it is needed, and its accomplishments so far
@en
Project BioShield: what it is, why it is needed, and its accomplishments so far
@nl
P3181
P356
P1476
Project BioShield: what it is, why it is needed, and its accomplishments so far
@en
P2093
Philip K Russell
P304
P3181
P356
10.1086/518151
P407
P478
45 Suppl 1
P577
2007-07-15T00:00:00Z